Hirokawa YS - Search Results

1

The 3'UTR of stem cell factor suppresses protein expression from a cotransfected vector.

Hirokawa YS, Watanabe M, Shiraishi T. Hirokawa YS, et al. Biochem Biophys Res Commun. 2003 Sep 19;309(2):469-74. doi: 10.1016/j.bbrc.2003.08.025. Biochem Biophys Res Commun. 2003. PMID: 12951073

2

Reduced heterochromatin protein 1-beta (HP1beta) expression is correlated with increased invasive activity in human melanoma cells.

Nishimura K, Hirokawa YS, Mizutani H, Shiraishi T. Nishimura K, et al. Among authors: hirokawa ys. Anticancer Res. 2006 Nov-Dec;26(6B):4349-56. Anticancer Res. 2006. PMID: 17201154 Free article.

3

High level expression of STAG1/PMEPA1 in an androgen-independent prostate cancer PC3 subclone.

Hirokawa YS, Takagi A, Uchida K, Kozuka Y, Yoneda M, Watanabe M, Shiraishi T. Hirokawa YS, et al. Cell Mol Biol Lett. 2007 Sep;12(3):370-7. doi: 10.2478/s11658-007-0009-y. Epub 2007 Feb 17. Cell Mol Biol Lett. 2007. PMID: 17318295 Free PMC article.

4

SOX11-induced decrease in vimentin and an increase in prostate cancer cell migration attributed to cofilin activity.

Hirokawa YS, Kanayama K, Kagaya M, Shimojo N, Uchida K, Imai H, Ishii K, Watanabe M. Hirokawa YS, et al. Exp Mol Pathol. 2020 Dec;117:104542. doi: 10.1016/j.yexmp.2020.104542. Epub 2020 Sep 21. Exp Mol Pathol. 2020. PMID: 32971115

5

Aberrant methylation of the vascular endothelial growth factor receptor-1 gene in prostate cancer.

Yamada Y, Watanabe M, Yamanaka M, Hirokawa Y, Suzuki H, Takagi A, Matsuzaki T, Sugimura Y, Yatani R, Shiraishi T. Yamada Y, et al. Cancer Sci. 2003 Jun;94(6):536-9. doi: 10.1111/j.1349-7006.2003.tb01479.x. Cancer Sci. 2003. PMID: 12824880 Free PMC article.

6

Genetic polymorphisms of hormone-related genes and prostate cancer risk in the Japanese population.

Fukatsu T, Hirokawa Y, Araki T, Hioki T, Murata T, Suzuki H, Ichikawa T, Tsukino H, Qiu D, Katoh T, Sugimura Y, Yatani R, Shiraishi T, Watanabe M. Fukatsu T, et al. Anticancer Res. 2004 Jul-Aug;24(4):2431-7. Anticancer Res. 2004. PMID: 15330195 Free article.

7

Identification of differentially methylated CpG islands in prostate cancer.

Yamada Y, Toyota M, Hirokawa Y, Suzuki H, Takagi A, Matsuzaki T, Sugimura Y, Yatani R, Shiraishi T, Watanabe M. Yamada Y, et al. Int J Cancer. 2004 Dec 10;112(5):840-5. doi: 10.1002/ijc.20335. Int J Cancer. 2004. PMID: 15386391

8

A G/A polymorphism in the androgen response element 1 of prostate-specific antigen gene correlates with the response to androgen deprivation therapy in Japanese population.

Shibahara T, Onishi T, Franco OE, Arima K, Nishikawa K, Yanagawa M, Hioki T, Watanabe M, Hirokawa Y, Shiraishi T, Sugimura Y. Shibahara T, et al. Anticancer Res. 2006 Sep-Oct;26(5A):3365-71. Anticancer Res. 2006. PMID: 17094454 Free article.

9

Epigenetic regulation of androgen receptor gene expression in human prostate cancers.

Nakayama T, Watanabe M, Suzuki H, Toyota M, Sekita N, Hirokawa Y, Mizokami A, Ito H, Yatani R, Shiraishi T. Nakayama T, et al. Lab Invest. 2000 Dec;80(12):1789-96. doi: 10.1038/labinvest.3780190. Lab Invest. 2000. PMID: 11140692 Free article.

10

The role of epigenetic modifications in retinoic acid receptor beta2 gene expression in human prostate cancers.

Nakayama T, Watanabe M, Yamanaka M, Hirokawa Y, Suzuki H, Ito H, Yatani R, Shiraishi T. Nakayama T, et al. Lab Invest. 2001 Jul;81(7):1049-57. doi: 10.1038/labinvest.3780316. Lab Invest. 2001. PMID: 11454993 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

68 results

Search Page

Filters